# US 2012/0237557 A1 · Bioactive carbon-nanotube agarose composites for neural engineering

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0237557 A1
- Document ID: US20120237557A1
- Status: Published application
- Kind: A1
- Application number: 13/308,510
- Filed: 2011-11-30
- Published: 2012-09-20
- Earliest claimed: 2010-11-30
- Assignees: Rutgers, The State University of New Jersey
- Inventors: Dan Lewitus; Joachim B. Kohn; Alexander Neimark; John Landers
- Web page: https://patentgrep.com/patent/US20120237557A1

## CPC

- A61K 47/6925: {the form being a microcapsule, nanocapsule, microbubble or nanobubble}
- A61K 9/70: Web, sheet or filament bases {; Films; Fibres of the matrix type containing drug (hollow drug-filled fibres A61K9/0092)}
- A61K 38/1774: {Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)}
- A61K 38/34: Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
- A61K 38/39: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A61K 9/0085: {Brain, e.g. brain implants; Spinal cord}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

Nanocomposite fibers containing one or more carbon nanotubes encapsulated in an polysaccharide gel matrix.

## Claims

### Claim 1

A nanocomposite fiber comprising one or more carbon nanotubes encapsulated in an polysaccharide gel matrix.

### Claim 2 (depends on 1)

The nanocomposite fiber of claim 1, wherein the polysaccharide is agarose.

### Claim 3 (depends on 1)

The nanocomposite fiber of claim 1, wherein the carbon nanotube is a single wall carbon nanotube.

### Claim 4 (depends on 1)

The nanocomposite fiber of claim 1, wherein the carbon nanotube is a multiwall carbon nanotube.

### Claim 5 (depends on 1)

The nanocomposite fiber of claim 1, wherein the carbon nanotube-based fiber has a functionalized surface that allows for the covalent attachment of one or more bioactive substances.

### Claim 6 (depends on 4)

The nanocomposite fiber of claim 4, wherein the bioactive substance is selected from the group consisting of proteins, peptides, glycogens and drugs.

### Claim 7 (depends on 4)

The nanocomposite of claim 4, wherein the bioactive substance is selected from the group consisting of laminin, alpha melanocyte stimulating hormone, and L1 cell adhesion molecule.

### Claim 8 (depends on 1)

The nanocomposite fiber of claim 1, wherein the fiber is loaded with at least one particle selected from the group consisting of platinum, palladium, gold, silver, titanium nitride, tantalum, tantalum oxide, iridium oxide and conductive polymers such as poly(3,4-ethylenedioxythiophene), polyimide, polyanyline, and polypyrole.

### Claim 9

A method for fabricating a biocompatible carbon nanotube-based nanocomposite fiber, comprising:
a) preparing a liquid dispersion solution comprising carbon nanotubes and a polysaccharide;
b) injecting the liquid dispersion solution into a rotating bath of ethanol to form pre-fibers; and
c) drying the pre-fibers.

### Claim 10 (depends on 9)

The method of claim 9, wherein the polysaccharide is agarose.

### Claim 11

A method for fabricating a biocompatible carbon nanotube-based fiber, comprising:
a) preparing a liquid dispersion solution comprising carbon nanotubes and a polysaccharide;
b) injecting the liquid dispersion solution into a tube;
c) allowing the liquid dispersion to form a molded gel in the tube;
d) removing the molded gel from the tube.

### Claim 12 (depends on 1)

The method of claim 1 wherein the polysaccharide is agarose.

### Claim 13 (depends on 5)

A method for delivering a desired biomolecule to a subject comprising the steps of:
a) loading the biocompatible carbon nanotube-based fiber of claim 5 with a desired biomolecule; and
b) contacting said subject with the complexed carbon nanotube-based fiber.

### Claim 14 (depends on 13)

The method of claim 13, wherein the polysaccharide is agarose.

### Claim 15 (depends on 14)

The method of claim 14, wherein the loading of the polymeric nanoparticle carrier comprises covalently attaching the desired biomolecule to the agarose.

### Claim 16 (depends on 13)

The method of claim 13, wherein the desired biomolecule is a drug.
